Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL NOUVELLE PHARMACIE DE LA VOIE ROMAINE : revenue, balance sheet and financial ratios

SELARL NOUVELLE PHARMACIE DE LA VOIE ROMAINE is a French company founded 4 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in NICE (06000), this company of category PME shows in 2024 a net income positive of 120 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL NOUVELLE PHARMACIE DE LA VOIE ROMAINE (SIREN 903437044)
Indicator 2024 2023 2022
Revenue N/C N/C N/C
Net income 119 508 € 192 070 € 110 657 €
EBITDA N/C N/C N/C
Net margin N/C N/C N/C

Revenue and income statement

In 2024, SELARL NOUVELLE PHARMACIE DE LA VOIE ROMAINE generates positive net income of 120 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2022-2024: 111 k€ -> 120 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

119 508 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 399%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 17%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

399.452%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

16.983%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

62.4%

Solvency indicators evolution
SELARL NOUVELLE PHARMACIE DE LA VOIE ROMAINE

Sector positioning

Debt ratio
399.45 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average

In 2024, the debt ratio of SELARL NOUVELLE PHARMACIE... (399.45) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
16.98% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch

In 2024, the financial autonomy of SELARL NOUVELLE PHARMACIE... (17.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 190.12. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

190.121

Liquidity indicators evolution
SELARL NOUVELLE PHARMACIE DE LA VOIE ROMAINE

Sector positioning

Liquidity ratio
190.12 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good +24 pts over 3 years

In 2024, the liquidity ratio of SELARL NOUVELLE PHARMACIE... (190.12) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of SELARL NOUVELLE PHARMACIE DE LA VOIE ROMAINE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELARL NOUVELLE PHARMACIE DE LA VOIE ROMAINE is estimated at 1 668 420 € (range 1 161 861€ - 2 496 051€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
1161k€ 1668k€ 2496k€
1 668 420 € Range: 1 161 861€ - 2 496 051€
NAF 5 année 2024

Valuation method used

Net Income Multiple
119 508 € × 14.0x = 1 668 420 €
Range: 1 161 861€ - 2 496 052€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL NOUVELLE PHARMACIE DE LA VOIE ROMAINE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL NOUVELLE PHARMACIE DE LA VOIE ROMAINE

What is the revenue of SELARL NOUVELLE PHARMACIE DE LA VOIE ROMAINE ?

The revenue of SELARL NOUVELLE PHARMACIE DE LA VOIE ROMAINE is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL NOUVELLE PHARMACIE DE LA VOIE ROMAINE profitable?

Yes, SELARL NOUVELLE PHARMACIE DE LA VOIE ROMAINE generated a net profit of 120 k€ in 2024.

Where is the headquarters of SELARL NOUVELLE PHARMACIE DE LA VOIE ROMAINE ?

The headquarters of SELARL NOUVELLE PHARMACIE DE LA VOIE ROMAINE is located in NICE (06000), in the department Alpes-Maritimes.

Where to find the tax return of SELARL NOUVELLE PHARMACIE DE LA VOIE ROMAINE ?

The tax return of SELARL NOUVELLE PHARMACIE DE LA VOIE ROMAINE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL NOUVELLE PHARMACIE DE LA VOIE ROMAINE operate?

SELARL NOUVELLE PHARMACIE DE LA VOIE ROMAINE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.